Leading UK Pharmacies trust Deltera
The Hepatitis A vaccine PGD allows pharmacists to supply and administer the vaccine to at-risk patients without a prescription. This service is essential for travel health clinics, providing protection for patients visiting high-risk regions or those with specific occupational risks, all managed through the Deltera digital clinical platform.
A Fully Digital Clinical Platform
Integrated Bookings and Payments
Secure & Connected Patient Records
Ditch the paperwork with secure digital records. Deltera automatically shares treatment summaries with the patient’s and sends the required notification to their GP instantly.
Training and Eligibility Requirements
To ensure clinical safety and regulatory compliance, all practitioners using this PGD must meet the following professional standards:
- Professional Registration: Must be a registered healthcare professional (e.g., Pharmacist) with a valid GPhC or PSNI registration and personal professional indemnity insurance.
- Clinical Competency: Practitioners must be self-certified as competent in the specific clinical area covered by this PGD and stay up to date with relevant national guidelines (e.g., The Green Book or NICE clinical summaries).
- Mandatory Training: Current certification in Basic Life Support (BLS) and the management of anaphylaxis is required for all injectable services.
- PGD Authorisation: The practitioner must have read and signed the PGD document within the Deltera Clinical Dashboard, with the authorisation counter-signed by the designated organisational lead or Superintendent.
- Premises Standards: Services must be conducted in a private consultation room that meets national standards for patient confidentiality and clinical safety.
Speak to the clinicians behind the platform
We understand the complexities of PGDs and clinical governance in the UK. Schedule a meeting with our team to see how we can help you navigate the changing landscape of community pharmacy.
Access related PGDs
FAQs
This PGD covers individuals requiring protection against the Hepatitis A virus, typically for travel or occupational hazards. Eligibility is determined via the integrated pre-screening tool in the Deltera portal.
Yes. This PGD covers the full course of Hepatitis A immunisation, including the initial primary dose and the subsequent booster (usually 6 to 12 months later) for long-term protection.
Eligibility depends on the specific protocol version. Most Hepatitis A PGDs include pediatric dosing; you can verify specific age limits within your Deltera dashboard.
If a patient falls outside the PGD criteria, the consultation can be transitioned to an Independent Prescriber via the Deltera IP Bridge, ensuring the patient still receives care.
Still have questions?
Our team are here to support you.
Discover Deltera Practice Management
Deltera Practice Management digitalises your private pharmacy services, providing the complete pharmacy software package to offer a full range of Patient Group Directions (PGDs). Gain the oversight and efficiency you need to thrive.
